Prixa raises US$3M to further expand its reach in the Indonesian healthcare market

Prixa, an Indonesia-based health tech startup that provides telemedicine and healthcare payment management service, announced a US$3 million funding round led by MDI Ventures and Trans-Pacific Technology Fund.

The funding round also includes the participation of existing investor Siloam Hospitals Group.

e27 has reached out to the company to find out more details about their previous funding rounds.

In a press statement, Prixa said that they will use the funding round to further expand the reach of its platform in the Indonesian market. It also aims to support its B2B user base while increasing access to healthcare and digital transformation in the country.

Founded in 2019 by James Roring, MD, the startup builds an Artificial Intelligence (AI)-based healthcare management platform that includes basic medical services such as telemedicine. It also includes features to support healthcare services payers, both individuals and corporates.

Prixa claimed to have secured 10 million users.

Also Read: WhiteCoat banks US$8M for its on-demand telemedicine services platform

According to Roring, there is a dichotomy in the current healthcare sector where the constant innovation in patients treatment does not go hand-in-hand with the increase of access to these healthcare services.

“Prixa was built to ease access to healthcare services through the use of technology which we use to help decrease healthcare expenses,” he said.

The pandemic and increased safety measures that are being implemented in many markets have opened plenty of opportunities for startups providing telemedicine services. In Indonesia, these startups include HaloDoc (which has announced a US$80 million Series C funding round in April) and Alodokter (which announced its Series C+ funding round in November 2020).

The World Health Organization (WHO) itself has noted that the COVID-19 pandemic has “significantly” impacted health services for noncommunicable diseases such as cancer and diabetes.

“It’s vital that countries find innovative ways to ensure that essential services for NCDs continue, even as they fight COVID-19,” said Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, in a statement.

Image Credit: Prixa

The post Prixa raises US$3M to further expand its reach in the Indonesian healthcare market appeared first on e27.

,

Prixa, an Indonesia-based health tech startup that provides telemedicine and healthcare payment management service, announced a US$3 million funding round led by MDI Ventures and Trans-Pacific Technology Fund.

The funding round also includes the participation of existing investor Siloam Hospitals Group.

e27 has reached out to the company to find out more details about their previous funding rounds.

In a press statement, Prixa said that they will use the funding round to further expand the reach of its platform in the Indonesian market. It also aims to support its B2B user base while increasing access to healthcare and digital transformation in the country.

Founded in 2019 by James Roring, MD, the startup builds an Artificial Intelligence (AI)-based healthcare management platform that includes basic medical services such as telemedicine. It also includes features to support healthcare services payers, both individuals and corporates.

Prixa claimed to have secured 10 million users.

Also Read: WhiteCoat banks US$8M for its on-demand telemedicine services platform

According to Roring, there is a dichotomy in the current healthcare sector where the constant innovation in patients treatment does not go hand-in-hand with the increase of access to these healthcare services.

“Prixa was built to ease access to healthcare services through the use of technology which we use to help decrease healthcare expenses,” he said.

The pandemic and increased safety measures that are being implemented in many markets have opened plenty of opportunities for startups providing telemedicine services. In Indonesia, these startups include HaloDoc (which has announced a US$80 million Series C funding round in April) and Alodokter (which announced its Series C+ funding round in November 2020).

The World Health Organization (WHO) itself has noted that the COVID-19 pandemic has “significantly” impacted health services for noncommunicable diseases such as cancer and diabetes.

“It’s vital that countries find innovative ways to ensure that essential services for NCDs continue, even as they fight COVID-19,” said Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, in a statement.

Image Credit: Prixa

The post Prixa raises US$3M to further expand its reach in the Indonesian healthcare market appeared first on e27.

Leave a Reply